{"nct_id":"NCT02861573","title":"Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2016-11-17","start_date_type":"ACTUAL","primary_completion_date":"2027-10-22","primary_completion_date_type":"ESTIMATED","completion_date":"2027-10-22","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}